SynBioBeta, a major gathering of the biotech world scheduled for earlier this month in San Jose, Calif. As the discussion’s ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...

Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions ...

Time to Invest? 10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue ...

Fiscal 2026 Outlook and Atara Launch Dynamics Full-year 2026 revenue guidance of $600 million to $625 million assumes ...

PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief executive officer, effective May ...

The Genomics England Research Environment provides access to Genomics England data, including genomes, variants and phenotypic data from rare disease and cancer patients from the 100,000 Genomes ...

The genomics community’s long wait for 10x Genomics’ highly anticipated news is finally over. On Saturday night, at the Hard Rock Café Hotel in San Diego—across the street from the American ...

Make money by identifying growth stocks, companies poised to grow faster than the market or average business in their industry. Genomics stocks are companies that study genes to improve people's lives ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.